506. Highly Efficient Treatment of Ph+ Acute Lymphoblastic Leukemia With a DNA Vaccine and 6-Mercaptopurine in Mice

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)37079-4
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Allopurinol Reverses Mercaptopurine-Induced Hypoglycemia in Patients With Acute Lymphoblastic Leukemia

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Optimal Predictor for 6-Mercaptopurine Intolerance in Chinese Children With Acute Lymphoblastic Leukemia: NUDT15, TPMT, or ITPA Genetic Variants?

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

The Impact of High-Dose Methotrexate on Intracellular 6-Mercaptopurine Disposition During Interval Therapy of Childhood Acute Lymphoblastic Leukemia

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

Upfront Treatment With the First and Second-Generation Tyrosine Kinase Inhibitors in Ph-Positive Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2017English

Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2000English

Measles and Rubella Vaccine Antibody Levels in Children With Acute Lymphoblastic Leukemia Following Chemotherapy

Journal of High Institute of Public Health
2013English

Molecular Emergence of Acute Myeloid Leukemia During Treatment for Acute Lymphoblastic Leukemia

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Acute Lymphoblastic Leukemia

2016English

Acute Lymphoblastic Leukemia

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy